Sign In
Buy LIFE
$16.89
-0.375 (-2.17%)
At Close: Jun 03, 2026
aTyr Pharma Inc (NASDAQ:LIFE) Expected to Post Quarterly Sales of $400,000.00
02:32am, Sunday, 21'st Jun 2020
Analysts expect aTyr Pharma Inc (NASDAQ:LIFE) to post sales of $400,000.00 for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for aTyr Pharma’s ear
Stocks To Watch: Nike, Apple, Ford And Stressed Banks
08:39am, Saturday, 20'th Jun 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
aTyr Pharma Highlights New Literature Implicating Neuropilin Pathway In SARS-CoV-2 Infection
09:01pm, Wednesday, 17'th Jun 2020
Discovery that Neuropilin b1 domain acts as a binding site for SARS-CoV-2 Spike protein and aids viral entry. Lead therapeutic candidate, ATYR1923, modulates Neuropilin pathway to dampen inflammatory
aTyr Pharma Highlights New Literature Implicating Neuropilin Pathway In SARS-CoV-2 Infection
12:00am, Wednesday, 17'th Jun 2020
Discovery that Neuropilin b1 domain acts as a binding site for SARS-CoV-2 Spike protein and aids viral entry. Lead therapeutic candidate, ATYR1923,...
SAN DIEGO, June 15, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathway
Atyr Pharma (LIFE) Upgraded to Buy: Here's What You Should Know
04:00pm, Friday, 12'th Jun 2020
Atyr Pharma (LIFE) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should You Buy aTyr Pharma Inc. (LIFE)?
02:43pm, Friday, 12'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Edited Transcript of LIFE earnings conference call or presentation 26-Mar-20 9:00pm GMT
09:27am, Tuesday, 02'nd Jun 2020
Q4 2019 aTyr Pharma Inc Earnings Call
aTyr Pharma to Present Poster at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
12:03pm, Wednesday, 20'th May 2020
SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
Atyr Pharma (LIFE) Q1 Earnings and Revenues Surpass Estimates
09:25pm, Tuesday, 12'th May 2020
Atyr Pharma (LIFE) delivered earnings and revenue surprises of 238.89% and 83.30%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Atyr Pharma: 1Q Earnings Snapshot
08:20pm, Tuesday, 12'th May 2020
SAN DIEGO (AP) _ Atyr Pharma Inc. (LIFE) on Tuesday reported first-quarter net income of $1.8 million, after reporting a loss in the same period a year earlier. The San Diego-based company...
SAN DIEGO, May 12, 2020 -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
